Pheton Holdings Limited (PTHL): Narxning sotuvga nisbati

Pheton Holdings Ltd (PTHL) tovar belgisi

Pheton Holdings Ltd (PTHL) Xitoy klinikalari bilan hamkorlik orqali maxsus braxiterapiya dasturiy ta'minotini joriy qilmoqda. Biznesning tor doiradagi yo'nalishi kuchli patent himoyasi bilan muvozanatlashgan, Osiyodagi texnologik bazasi esa innovatsion IT yechimlarning ishlab chiqilishini osonlashtiradi. GURU.Markets platformasi kompaniya uchun ushbu normallashtirilgan P/S koeffitsiyentini taqdim etadi, bunda 27.50 metrikaning joriy qiymatini belgilab, aktivning bozor qiymatini uning daromadiga nisbatan baholash imkonini beradi.

PTHL: Pheton Holdings Ltd P/S multiplikatori 06.09.2024 - 16.01.2026

Pheton Holdings Ltd (PTHL) kompaniyasi koʻrsatkichlari kesimi va tahlili

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
Kompaniyaning fundamental tahlili:ftzy.com.cn (PTHL)
Pheton brendining mahsuloti

P/S koeffitsiyenti biznes kapitalizatsiyasini yillik savdo hajmining ko'rsatkichiga bo'lish orqali bir dollar daromadning bozor qiymatini belgilaydi. Ushbu metrika investorga aktivlarning haddan tashqari qiziganlik darajasini va strukturaviy transformatsiya davrlarida kapitalning muzlab qolish xavfini baholash imkonini beradi. Kapitalizatsiyaning daromadga nisbati dinamikasini tahlil qilish orqali Xitoydagi tartibga soluvchi to'siqlar va yuqori R&D xarajatlarining ta'sirini kuzatish mumkin. Ushbu omillar Pheton Holdings Ltd (PTHL) kompaniyasining daromadliligini cheklab, uning fundamental baholanishiga bosim o'tkazmoqda.

Pheton Holdings Ltd kimlar bilan raqobatlashadi

HLN (Haleon) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Kenvue Inc KVUE|Verona Pharma Corp - Narxning daromadga nisbati|MENS: Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti Ligand Pharmaceuticals LGND|Amneal Pharmaceuticals Inc (AMRX) - Narxning daromadga nisbati|Perrigo Company PLC - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati alvotech.com|P/S multiplikatori Liquidia Technologies|Narxning daromadga nisbati Galapagos Genomics (GLPG)|ANIP: Narxning sotuvga nisbati|P/S multiplikatori MNKD (MannKind Corp)|Narx/daromad koeffitsiyenti Amphastar (AMPH)|PCRX: Kapitalizatsiyaning daromadga nisbati|SPRY - P/S multiplikatori|Theravance Biopharma, Inc. (TBPH) - Narxning daromadga nisbati|AQST (Aquestive Therapeutics) - Narxning daromadga nisbati|SCPH (scpharmaceuticals.com) - P/S multiplikatori|TECX: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Tonix Pharmaceuticals Inc. (TNXP)|SXTC (SXT Pharmaceuticals) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori EPRX (Eupraxia Pharmaceuticals)|Bozor kapitallashuvining daromadga nisbati BHST|Invizyne Technologies - P/S multiplikatori|oramed.com (ORMP) - Kapitalizatsiyaning daromadga nisbati|ENTX (enterabio.com) - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiya va daromad nisbati HYFT|ABVC (ABVC BioPharma, Inc) - P/S multiplikatori|P/S multiplikatori cumberlandpharma.com|Narxning daromadga nisbati Quantum BioPharma (QNTM)|FibroGen (FGEN) - Narx/daromad multiplikatori|P/S multiplikatori TELO (telomirpharma.com)|RANI - Kapitalizatsiyaning daromadga nisbati|SNYR - Narxning daromadga nisbati|rallybio.com - Kapitalizatsiyaning sotish hajmiga nisbati|LEXX: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Pulmatrix Inc|APM (Aptorum Group Ltd) - P/S multiplikatori|Lyra Therapeutics Inc (LYRA) - Narx/daromad koeffitsiyenti|P/S multiplikatori IBO|Kapitalizatsiyaning sotish hajmiga nisbati TNFA|cbdMD, Inc. - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati PRFX|Altamira Therapeutics Ltd. - P/S multiplikatori|LIPO: Narxning daromadga nisbati|OPTN: P/S multiplikatori|Narxning sotuvga nisbati PIRS (Pieris Pharmaceuticals)|PROC (Procaps) - P/S multiplikatori|PTPI (Petros Pharmaceuticals Inc) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori QLI|SLRN - Sotuvga nisbatan narx|P/S multiplikatori TFFP (TFF Pharmaceuticals, Inc)